Seer, Inc. (SEER): Cash & Equivalents

Annual figures by period end, from SEC filings.

$47.28M
As of 2025-12-31
$26.07M
As of 2026-06-30
-3.9%
3-year compound annual growth
-32.3%
5-year compound annual growth
$333.58M2020-12-31: $333.58M2021-12-31: $232.81M2022-12-31: $53.21M2023-12-31: $32.50M2024-12-31: $40.75M2025-12-31: $47.28M$47.28M
2020-12-31 Cash & Equivalents (USD) 2025-12-31
Period endedCash & EquivalentsChange YoYSource filing
2025-12-31$47.28M+16.0%2026-03-02, Balance as of period end
2024-12-31$40.75M+25.4%2026-03-02, Balance as of period end
2023-12-31$32.50M-38.9%2025-03-03, Balance as of period end
2022-12-31$53.21M-77.1%2024-03-04, Balance as of period end
2021-12-31$232.81M-30.2%2023-03-06, Balance as of period end
2020-12-31$333.58Mn/a2022-03-01, Balance as of period end

Cash & Equivalents at similar companies

Companies with the same SEC industry code (Laboratory Analytical Instruments), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCash & EquivalentsChange YoY
Seer, Inc. (SEER)2025-12-31$47.28M+16.0%
Precipio, Inc. (PRPO)2025-12-31$2.65M+90.9%
Bionano Genomics, Inc. (BNGO)2025-12-31$2.99M-67.4%
EyePoint, Inc. (EYPT)2025-12-31$101.82M+2.1%
Rapid Micro Biosystems, Inc. (RPID)2025-12-31$20.03M+18.4%
908 Devices Inc. (MASS)2025-12-31$70.52M+60.1%
Harvard Bioscience Inc (HBIO)2025-12-31$8.61M+109.7%
Quanterix Corp (QTRX)2025-12-31$29.84M-47.4%
Pacific Biosciences of California, Inc. (PACB)2025-12-31$63.71M+15.1%

Compare SEER, PRPO, BNGO, EYPT side by side · Screen every company in Laboratory Analytical Instruments ↗